Joon Lee
Stock Analyst at Truist Securities
(4.87)
# 64
Out of 5,116 analysts
111
Total ratings
66.36%
Success rate
49.8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Joon Lee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BMRN BioMarin Pharmaceutical | Maintains: Buy | $80 → $100 | $59.95 | +66.81% | 4 | Dec 23, 2025 | |
| WVE Wave Life Sciences | Maintains: Buy | $36 → $50 | $17.77 | +181.37% | 4 | Dec 15, 2025 | |
| PRAX Praxis Precision Medicines | Maintains: Buy | $360 → $500 | $268.95 | +85.91% | 7 | Dec 8, 2025 | |
| ALKS Alkermes | Maintains: Buy | $50 → $55 | $28.49 | +93.05% | 3 | Nov 17, 2025 | |
| NTLA Intellia Therapeutics | Reiterates: Buy | $25 → $14 | $9.44 | +48.31% | 5 | Nov 10, 2025 | |
| RARE Ultragenyx Pharmaceutical | Maintains: Buy | $100 → $90 | $34.19 | +163.23% | 1 | Nov 5, 2025 | |
| RAPP Rapport Therapeutics | Initiates: Buy | $44 | $30.20 | +45.70% | 1 | Sep 16, 2025 | |
| ARGX argenx SE | Maintains: Buy | $700 → $918 | $844.92 | +8.65% | 13 | Sep 15, 2025 | |
| VRTX Vertex Pharmaceuticals | Maintains: Buy | $520 → $490 | $462.90 | +5.85% | 4 | Aug 5, 2025 | |
| PTCT PTC Therapeutics | Maintains: Buy | $80 → $86 | $78.52 | +9.53% | 2 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $95 → $75 | $37.18 | +101.72% | 8 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $65 → $21 | $12.16 | +72.70% | 6 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $76 → $150 | $82.65 | +81.49% | 8 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $190 → $200 | $152.05 | +31.54% | 5 | Feb 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $120 | $55.08 | +117.86% | 5 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $3.93 | +358.02% | 1 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $5.84 | +173.97% | 1 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $36 | $24.35 | +47.84% | 7 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $8 | $2.17 | +268.66% | 7 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $17 | $12.53 | +35.67% | 7 | Oct 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $200 | $170.48 | +17.32% | 2 | Mar 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $5 | $5.83 | -14.24% | 7 | Sep 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $4.08 | +341.18% | 1 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $280 | $1.35 | +20,640.74% | 1 | Oct 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $27 → $34 | $50.10 | -32.14% | 1 | Mar 16, 2021 |
BioMarin Pharmaceutical
Dec 23, 2025
Maintains: Buy
Price Target: $80 → $100
Current: $59.95
Upside: +66.81%
Wave Life Sciences
Dec 15, 2025
Maintains: Buy
Price Target: $36 → $50
Current: $17.77
Upside: +181.37%
Praxis Precision Medicines
Dec 8, 2025
Maintains: Buy
Price Target: $360 → $500
Current: $268.95
Upside: +85.91%
Alkermes
Nov 17, 2025
Maintains: Buy
Price Target: $50 → $55
Current: $28.49
Upside: +93.05%
Intellia Therapeutics
Nov 10, 2025
Reiterates: Buy
Price Target: $25 → $14
Current: $9.44
Upside: +48.31%
Ultragenyx Pharmaceutical
Nov 5, 2025
Maintains: Buy
Price Target: $100 → $90
Current: $34.19
Upside: +163.23%
Rapport Therapeutics
Sep 16, 2025
Initiates: Buy
Price Target: $44
Current: $30.20
Upside: +45.70%
argenx SE
Sep 15, 2025
Maintains: Buy
Price Target: $700 → $918
Current: $844.92
Upside: +8.65%
Vertex Pharmaceuticals
Aug 5, 2025
Maintains: Buy
Price Target: $520 → $490
Current: $462.90
Upside: +5.85%
PTC Therapeutics
Jul 29, 2025
Maintains: Buy
Price Target: $80 → $86
Current: $78.52
Upside: +9.53%
Apr 28, 2025
Reiterates: Buy
Price Target: $95 → $75
Current: $37.18
Upside: +101.72%
Apr 9, 2025
Maintains: Buy
Price Target: $65 → $21
Current: $12.16
Upside: +72.70%
Mar 31, 2025
Maintains: Buy
Price Target: $76 → $150
Current: $82.65
Upside: +81.49%
Feb 19, 2025
Maintains: Buy
Price Target: $190 → $200
Current: $152.05
Upside: +31.54%
Feb 12, 2025
Maintains: Buy
Price Target: $100 → $120
Current: $55.08
Upside: +117.86%
Jan 29, 2025
Initiates: Buy
Price Target: $18
Current: $3.93
Upside: +358.02%
Jan 8, 2025
Initiates: Buy
Price Target: $16
Current: $5.84
Upside: +173.97%
Nov 11, 2024
Maintains: Buy
Price Target: $30 → $36
Current: $24.35
Upside: +47.84%
Nov 5, 2024
Maintains: Buy
Price Target: $12 → $8
Current: $2.17
Upside: +268.66%
Oct 22, 2024
Maintains: Buy
Price Target: $12 → $17
Current: $12.53
Upside: +35.67%
Mar 20, 2024
Reiterates: Buy
Price Target: $200
Current: $170.48
Upside: +17.32%
Sep 20, 2023
Maintains: Buy
Price Target: $6 → $5
Current: $5.83
Upside: -14.24%
May 10, 2023
Initiates: Buy
Price Target: $18
Current: $4.08
Upside: +341.18%
Oct 20, 2021
Initiates: Buy
Price Target: $280
Current: $1.35
Upside: +20,640.74%
Mar 16, 2021
Upgrades: Buy
Price Target: $27 → $34
Current: $50.10
Upside: -32.14%